Recombinant multi-species UROD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UROD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an enzyme in the heme biosynthetic pathway. This enzyme is responsible for catalyzing the conversion of uroporphyrinogen to coproporphyrinogen through the removal of four carboxymethyl side chains. Mutations and deficiency in this enzyme are known to cause familial porphyria cutanea tarda and hepatoerythropoetic porphyria.[provided by RefSeq, Aug 2010]
The Alternative Names of target: PCT,UPD,URO-D,UROD,Uro-d,Urod,Uroporphyrinogen decarboxylase,porphyrinogen carboxy-lyase

Target products collectionGo to UROD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11911-Ag-1/ GM-Tg-hg-IP11911-Ag-2 Human UROD protein Human
GM-Tg-rg-IP11911-Ag-1/ GM-Tg-rg-IP11911-Ag-2 Rat UROD protein Rat
GM-Tg-mg-IP11911-Ag-1/ GM-Tg-mg-IP11911-Ag-2 Mouse UROD protein Mouse
GM-Tg-cynog-IP11911-Ag-1/ GM-Tg-cynog-IP11911-Ag-2 Cynomolgus/Rhesus macaque UROD protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11911-Ag-1/ GM-Tg-felg-IP11911-Ag-2 Feline UROD protein Feline
GM-Tg-cang-IP11911-Ag-1/ GM-Tg-cang-IP11911-Ag-2 Canine UROD protein Canine
GM-Tg-bovg-IP11911-Ag-1/ GM-Tg-bovg-IP11911-Ag-2 Bovine UROD protein Bovine
GM-Tg-equg-IP11911-Ag-1/ GM-Tg-equg-IP11911-Ag-2 Equine UROD protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11911-Ag-1/ GM-Tg-hg-IP11911-Ag-2; GM-Tg-rg-IP11911-Ag-1/ GM-Tg-rg-IP11911-Ag-2;
GM-Tg-mg-IP11911-Ag-1/ GM-Tg-mg-IP11911-Ag-2; GM-Tg-cynog-IP11911-Ag-1/ GM-Tg-cynog-IP11911-Ag-2;
GM-Tg-felg-IP11911-Ag-1/ GM-Tg-felg-IP11911-Ag-2; GM-Tg-cang-IP11911-Ag-1/ GM-Tg-cang-IP11911-Ag-2;
GM-Tg-bovg-IP11911-Ag-1/ GM-Tg-bovg-IP11911-Ag-2; GM-Tg-equg-IP11911-Ag-1/ GM-Tg-equg-IP11911-Ag-2
Products Name UROD protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name UROD
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UROD protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.